Medtronic's (NYSE:MDT) stand-alone diabetes company, first announced in May, will be known as MiniMed. MiniMed was the ...

Medtronic has announced plans to separate out its diabetes business into a new standalone company. The separation will serve to create an “independent, scaled leader in diabetes” that boasts ...

The Diabetes GCC will be a centre of excellence that aims to enhance customer care, advanced analytics, and digital tech ...

Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity ...

Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction a ...

Medtronic Plc invests $50 million in new Pune Global Capability Centre for diabetes operations, creating 300 jobs initially.

Medtronic (NYSE:MDT) announced that it inaugurated a new Diabetes Global Capability Center in India with a significant ...

Medtronic said. The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year, ending in April, up 10.7% from the prior year. Medtronic reported more than $34 billion ...

Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently returned to ...

Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management GALWAY, Ireland, May 21 ...

2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a new standalone company ("New Diabetes ...